SCHEMBL23048845

SCHEMBL23048845

C/C=C\c1cccc(N2CCN(C)CC2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 1/20 0.57
HDAC3 O15379 3/20 0.50
HDAC4 P56524 3/20 0.50
HDAC1 Q13547 3/20 0.50
HDAC7 Q8WUI4 3/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC10 Q969S8 3/20 0.50
HDAC11 Q96DB2 3/20 0.50
HDAC8 Q9BY41 3/20 0.50
HDAC6 Q9UBN7 3/20 0.50
HDAC9 Q9UKV0 3/20 0.50
HDAC5 Q9UQL6 3/20 0.50
ABCB1 P08183 2/20 0.48
AGXT P21549 1/20 0.48
HTR3A P46098 1/20 0.47
ALDH1A1 P00352 1/20 0.45
MAPT P10636 3/20 0.43
HRH4 Q9H3N8 1/20 0.43
GAA P10253 2/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28199225 0.93 ADRA2C (0.46) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL5610645 0.86 PRMT6 (0.45) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL3584889 0.86 ADRA2C (0.61) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL28090296 0.85 PRMT6 (0.47) ADRA2CHDAC4ABCB1AGXTALDH1A1
SCHEMBL23916588 0.83 ADRA2C (0.61) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL14261396 0.82 MAPT (0.50) HDAC4ABCB1AGXTALDH1A1MAPT
SCHEMBL29442412 0.81 ALDH1A1 (0.64) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL1444185 0.81 ALDH1A1 (0.64) ADRA2CHDAC3HDAC4HDAC1HDAC7
SCHEMBL28201788 0.77 MAPT (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL1559226 0.75 ADRA2C (0.65) ADRA2CHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3448386-B1 ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF SAMUMED LLC (US) 2021-03-03 EP disclosed